MicroRNA-128-3p impaired water maze learning by suppressing Doublecortin expression in both wild type and Aβ-42

Jinlong Chen1, Wen Li1, Yuan Li1

  • 1CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China.

Insights

MicroRNA-128 (miR-128) suppresses Doublecortin (Dcx) expression, impacting neural stem cell differentiation and hippocampus-dependent learning. This miR-128-Dcx axis is crucial for cognitive function and affected by amyloid-beta in Alzheimer's models.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-128 (miR-128) is abundant in the brain and targets Doublecortin (Dcx), a critical factor in adult neurogenesis.
  • The precise physiological consequences of the miR-128-Dcx interaction in vivo are not fully understood.

Purpose of the Study:

  • To elucidate the functional role of the miR-128-Dcx regulatory axis in neurogenesis and hippocampus-dependent learning.
  • To investigate the involvement of this axis in an Alzheimer's disease model.

Main Methods:

  • Utilized lentivirus systems for overexpressing miR-128 and Dcx in neural stem cells and mouse hippocampi.
  • Assessed neurogenesis by quantifying TuJ+ cells.
  • Evaluated learning and memory using the water maze task.
  • Induced an Alzheimer's-like state using Aβ-42 infusion.

Main Results:

  • miR-128 directly suppressed Dcx expression by binding to its 3'UTR.
  • Overexpression of miR-128 inhibited neural stem cell differentiation and impaired water maze learning.
  • Simultaneous Dcx restoration attenuated miR-128-induced learning deficits.
  • Alzheimer's model (Aβ-42 infusion) showed increased miR-128, decreased Dcx, and learning impairments, partially reversed by Dcx overexpression.

Conclusions:

  • The miR-128-Dcx regulatory axis is essential for normal hippocampus-dependent learning.
  • Dysregulation of this axis contributes to cognitive deficits in an Alzheimer's disease model.
  • Targeting the miR-128-Dcx pathway may offer therapeutic potential for cognitive impairment.

Related Concept Videos